Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activation
L Klimek, N Novak, B Cabanillas, M Jutel, J Bousquet… - Allergy, 2021 - Wiley Online Library
Following the emergency use authorization of the mRNA‐1273 vaccine on the 18th of
December 2020, two mRNA vaccines are in current use for the prevention of coronavirus …
December 2020, two mRNA vaccines are in current use for the prevention of coronavirus …
Potential therapeutic targets and vaccine development for SARS-CoV-2/COVID-19 pandemic management: a review on the recent update
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly pathogenic
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …
Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID‐19 vaccination
Background As more people become vaccinated against the SARS‐CoV‐2 virus, reports of
delayed cutaneous hypersensitivity reactions are beginning to emerge. Methods In this IRB …
delayed cutaneous hypersensitivity reactions are beginning to emerge. Methods In this IRB …
[HTML][HTML] Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
The concepts of developing RNAs as new molecular entities for therapies have arisen again
and again since the discoveries of antisense RNAs, direct RNA-protein interactions …
and again since the discoveries of antisense RNAs, direct RNA-protein interactions …
Gender differences in the determinants of willingness to get the COVID-19 vaccine among the working-age population in Japan
T Ishimaru, M Okawara, H Ando, A Hino… - Human Vaccines & …, 2021 - Taylor & Francis
Many factors are related to vaccination intentions. However, gender differences in the
determinants of intention to get the coronavirus disease 2019 (COVID-19) vaccine have not …
determinants of intention to get the coronavirus disease 2019 (COVID-19) vaccine have not …
A systematic review on mucocutaneous presentations after COVID‐19 vaccination and expert recommendations about vaccination of important immune‐mediated …
F Seirafianpour, H Pourriyahi… - Dermatologic …, 2022 - Wiley Online Library
With dermatologic side effects being fairly prevalent following vaccination against COVID‐
19, and the multitude of studies aiming to report and analyze these adverse events, the need …
19, and the multitude of studies aiming to report and analyze these adverse events, the need …
Clinical and molecular characterization of a rare case of BNT162b2 mRNA COVID-19 vaccine-associated myositis
Initial clinical trials and surveillance data have shown that the most commonly administered
BNT162b2 COVID-19 mRNA vaccine is effective and safe. However, several cases of mRNA …
BNT162b2 COVID-19 mRNA vaccine is effective and safe. However, several cases of mRNA …
Allergic reactions to COVID-19 vaccines: risk factors, frequency, mechanisms and management
N Luxi, A Giovanazzi, A Arcolaci, P Bonadonna… - BioDrugs, 2022 - Springer
Conventional vaccines have been widely studied, along with their risk of causing allergic
reactions. These generally consist of mild local reactions and only rarely severe …
reactions. These generally consist of mild local reactions and only rarely severe …
Olfactory and gustatory disorders in COVID-19
L Klimek, J Hagemann, J Döge… - Allergo journal …, 2022 - Springer
Loss of olfaction is one of the symptoms most commonly reported by patients with
coronavirus disease 2019 (COVID-19). Although the spontaneous recovery rate is high …
coronavirus disease 2019 (COVID-19). Although the spontaneous recovery rate is high …
[HTML][HTML] The intestinal microbiota and improving the efficacy of COVID-19 vaccinations
Most COVID-19 cases are mild or asymptomatic and recover well, suggesting that effective
immune responses ensue, which successfully eliminate SARS-CoV-2 viruses. However, a …
immune responses ensue, which successfully eliminate SARS-CoV-2 viruses. However, a …